menu toggle

Insights

Perspective, tips, and resources for moving health forward

abstract-brand-colors-texture-2
All Insights Health Systems Pharmacies Physician Practices Manufacturers Animal Health
AmerisourceBergen

A Biosimilars Roadmap: Understanding Payer Perceptions

Inverted color AmerisourceBergen icon
AmerisourceBergen
May 2024

Manufacturers

Webinar: Bracing for the Impact of Biosimilars: Navigating Terrain in the U.S. Market Landscape

AB-TB-Sq-Block
FormularyDecisions
May 2024
Chemical chain

Physician Practices

Biosimilars pipeline report: A guide for understanding the growing market 

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2024
access network

Manufacturers

Biosimilars pipeline report: A guide for understanding the growing market

Inverted color AmerisourceBergen icon
AmerisourceBergen
March 2024
Biosimilar_2020_Pipeline

Manufacturers

Cencora's Brian Biehn and Corey Ford recommend adaptations for biosimilar regulatory frameworks

Inverted color AmerisourceBergen icon
AmerisourceBergen
January 2024
biosimilar_vials

Manufacturers

Podcast: How 2023 will shape the US Biosimilar space for 2024 and beyond

Inverted color AmerisourceBergen icon
AmerisourceBergen
January 2024
Vials

Manufacturers

Cencora's Brian Biehn Forecasts Big Changes for the US Biosimilar Space

Inverted color AmerisourceBergen icon
AmerisourceBergen
December 2023
Manufacturer of biosimilars

Manufacturers

Untangle the complexities of launching a biosimilar

AB-TB-Sq-Block
AmerisourceBergen
October 2023
Family plays cat's cradle

Manufacturers

Recap Asembia 2023: Our impactful contributions to the premier specialty pharmacy conference

Inverted color AmerisourceBergen icon
AmerisourceBergen
May 2023
Amerisourcebergen representatives at Asembia

Manufacturers

Education: The centerpiece of biosimilar adoption

Inverted color AmerisourceBergen icon
AmerisourceBergen
February 2023
Biosimilars adoption

Manufacturers

Podcast: Conversations around interchangeability and biosimilar entries in new therapeutic categories

Inverted color AmerisourceBergen icon
AmerisourceBergen
September 2022
Interchangeable biosimilars

Manufacturers

Podcast: Milestones for biosimilars in 2022 and looking ahead to 2023

Inverted color AmerisourceBergen icon
AmerisourceBergen
July 2022
Biosimilars podcast

Manufacturers

Why biopharma companies must understand barriers to biosimilar adoption

Inverted color AmerisourceBergen icon
AmerisourceBergen
May 2022
barriers to biosimilar adoption

Podcast: Insulin biosimilars part 2

Inverted color AmerisourceBergen icon
AmerisourceBergen
August 2021
Insulin consultation

Podcast: Insulin biosimilars part 1

Inverted color AmerisourceBergen icon
AmerisourceBergen
July 2021
Insulin model texture

Manufacturers

Webinar: uptake or heartbreak with biosimilars? Progress and perspectives

Inverted color AmerisourceBergen icon
AmerisourceBergen
February 2021
Market access professionals

Health Systems

Biosimilars: Patents, policy, and reimbursement

SeanMcGowan
Sean McGowan; Steve Miller; David Senior
AmerisourceBergen
October 2020
microphone

Manufacturers

Physician Q&A: How to Boost Confidence in Biosimilars

Patel
Kashyap Patel, MD
Carolina Blood and Cancer Care
February 2020
DNA_blue_vial

Manufacturers

Video: Removing Barriers for Biosimilars

Inverted color AmerisourceBergen icon
AmerisourceBergen
February 2020
biosims video thumb1

Manufacturers

Biosimilars Check Up: Part 2

Inverted color AmerisourceBergen icon
AmerisourceBergen
December 2019

We asked 100 physicians to share their perspectives on biosimilar utilization, cost savings, and adoption barriers. See what they said and what it means for the market and manufacturers.

Manufacturers

Infographic: Physician Perspectives on Biosimilars

Inverted color AmerisourceBergen icon
AmerisourceBergen
December 2019
biosims_micro

Manufacturers

Biosimilars: Market Insights and Growth Factors

SeanMcGowan
Sean McGowan; Rick Lozano
AmerisourceBergen
September 2019

The growth of biosimilars presents a significant opportunity to reduce the cost of care and provide patients with greater access to affordable treatments. Our experts assess the current state and future of the biosimilars market.

Manufacturers

Biosimilars: Launch Insights From the Field

Inverted color AmerisourceBergen icon
Xcenda
September 2019

How are biosimilar manufacturers approaching patients, providers and payers? What can they do to differentiate? Xcenda shares insight from our field programs.

Manufacturers

Biosimilars: Shaping a Moving Market

Inverted color AmerisourceBergen icon
AmerisourceBergen
September 2019

An animated, immersive biosimilar market snapshot with actionable insight for manufacturers.

Manufacturers

Biosimilars Check Up: Physician Survey Results

Inverted color AmerisourceBergen icon
AmerisourceBergen
September 2019

We asked 100 physicians to share their perspectives on biosimilar utilization, cost savings, and adoption barriers. See what they said and what it means for the market and manufacturers.

Manufacturers

The Growth of Biosimilars in the Oncology Pipeline

picard
Dave Picard
AmerisourceBergen
September 2017

What should biosimilar manufacturers focus on for commercialization success?

Manufacturers

Improving Customer Experience and Driving Long-Term Value for Manufacturers

Rich_Tremonte_Seamless_1_2016
Rich Tremonte
AmerisourceBergen
August 2017

Rich Tremonte on the current healthcare landscape, the role of the wholesaler and how the new organizational structure at AmerisourceBergen brings out the best in both.